Lam Research Corporation (LRCX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on January 27, 2025, by Lam Research Corporation, a Delaware corporation. The filing discloses the entry into a material definitive agreement regarding the company's credit facilities.
Key Financial Metrics and Debt Structure
The filing details the amendment of the company's revolving unsecured credit facility. As of the filing date, no principal amount was outstanding under the new facility.
- Revolving Credit Facility: Increased from $1.5 billion to $2.0 billion.
- Expansion Option: Available to increase the facility by up to an additional $750 million, for a potential total commitment of $2.750 billion.
- Maturity Date: January 25, 2030.
- Interest Rates: Base rate plus 0.00% to 0.10% OR Adjusted Term SOFR plus 0.70% to 1.10%, plus a facility fee based on credit rating.
- Financial Covenant: Consolidated funded debt to adjusted EBITDA ratio must remain at or below 3.50:1.00 (temporarily up to 4.00:1.00 for material acquisitions).
Material Changes Versus Prior Period
The primary material change is the amendment and restatement of the Second Amended and Restated Credit Agreement dated June 17, 2021. The key change is the $500 million increase in the revolving credit facility capacity and the extension of the maturity date to 2030.
Guidance, Outlook, and Risks
The filing does not provide specific revenue guidance, profit outlook, or management commentary on operational performance. Proceeds from the facility are designated for general corporate purposes.
Risks and Contingencies:
- Covenants: The agreement includes customary affirmative and negative covenants, including limitations on liens, mergers, and changes in the nature of the business.
- Events of Default: Includes payment defaults, breaches of covenants, cross-defaults, bankruptcy, and change of control, which could trigger immediate repayment of obligations.
Key Facts for Investor Verification
- Verify the current credit rating of Lam Research Corporation to determine the applicable interest rate spread and facility fee.
- Confirm the company's current consolidated funded debt to adjusted EBITDA ratio to ensure compliance with the 3.50:1.00 covenant.
- Review the full text of Exhibit 10.1 for specific definitions of "Adjusted EBITDA" and conditions for the expansion option.
- Monitor future usage of the $2.0 billion facility, as no amounts were outstanding as of January 27, 2025.